3. Exactech (Nasdaq:EXAC): +81.1%
The orthopedic implant company is an acquisition target – and it’s been increasing in value. Exactech (Gainesville, Fla.) announced last month that TPG Capital had raised its go-private bid for the company by about $108 million, or more than 17%.
The company makes orthopedic implants and surgical instruments for hip, knee and shoulder replacement and spine surgery. It also produces biologic materials and bone cement systems.